Header cover image

South Korean (KOSPI) Biotech Industry Analysis

UpdatedNov 29, 2023
DataAggregated Company Financials
Companies111
  • 7D-0.4%
  • 3M-0.3%
  • 1Y-6.1%
  • YTD-1.5%

Over the last 7 days, the Biotech industry has remained flat, although notably ALTEOGEN gained 10%. Unfortunately though, the industry is down 6.1% over the past 12 months. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the South Korean Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 Nov 2023₩59.0t₩10.1t-₩315,765,649,899.0026.1x-186.7x5.8x
Fri, 27 Oct 2023₩52.2t₩10.2t-₩239,053,318,689.0027.8x-218.4x5.1x
Sun, 24 Sep 2023₩55.7t₩10.2t-₩239,053,318,689.0028.8x-233.1x5.5x
Tue, 22 Aug 2023₩57.5t₩10.2t-₩213,622,992,279.0036.8x-269.1x5.6x
Thu, 20 Jul 2023₩56.4t₩10.3t-₩151,534,704,579.0025.9x-372.4x5.5x
Sat, 17 Jun 2023₩60.8t₩10.3t-₩151,534,704,579.0029.8x-401.1x5.9x
Mon, 15 May 2023₩61.2t₩11.0t₩317.8b26.5x192.5x5.6x
Wed, 12 Apr 2023₩63.3t₩11.0t₩318.9b24.2x198.4x5.7x
Fri, 10 Mar 2023₩58.8t₩11.3t₩964.4b25.6x61x5.2x
Sun, 05 Feb 2023₩61.6t₩11.3t₩970.8b25x63.5x5.4x
Tue, 03 Jan 2023₩58.1t₩11.4t₩685.0b23.2x84.8x5.1x
Thu, 01 Dec 2022₩60.4t₩10.8t₩189.9b23.8x317.9x5.6x
Sat, 29 Oct 2022₩59.7t₩10.8t₩348.0b19.1x171.4x5.5x
Mon, 26 Sep 2022₩57.4t₩10.8t₩391.5b20.9x146.7x5.3x
Wed, 24 Aug 2022₩68.6t₩10.8t₩617.8b23.3x111x6.3x
Fri, 22 Jul 2022₩70.5t₩10.7t₩597.6b26.6x117.9x6.6x
Sun, 19 Jun 2022₩61.4t₩10.6t₩627.1b23.4x97.9x5.8x
Tue, 17 May 2022₩63.7t₩10.0t₩871.1b25.8x73.1x6.4x
Thu, 14 Apr 2022₩72.0t₩10.0t₩898.1b27.6x80.1x7.2x
Sat, 12 Mar 2022₩75.1t₩9.4t₩746.5b34.8x100.7x8x
Mon, 07 Feb 2022₩75.6t₩9.4t₩787.4b33.5x96x8.1x
Wed, 05 Jan 2022₩91.3t₩9.4t₩787.4b39.1x116x9.7x
Fri, 03 Dec 2021₩94.0t₩9.4t₩790.0b41.4x119x10x
Sun, 31 Oct 2021₩94.4t₩9.2t₩988.3b38.5x95.5x10.2x
Tue, 28 Sep 2021₩115.3t₩9.2t₩986.1b43.2x116.9x12.5x
Thu, 26 Aug 2021₩118.8t₩9.3t₩909.7b50.7x130.6x12.8x
Fri, 02 Jul 2021₩106.9t₩9.3t₩909.7b53.7x117.5x11.5x
Mon, 05 Apr 2021₩103.5t₩9.0t₩979.0b41.2x105.7x11.5x
Thu, 07 Jan 2021₩107.7t₩8.2t₩501.3b54.1x214.9x13.1x
Price to Earnings Ratio

404.2x


Total Market Cap: ₩96.4tTotal Earnings: ₩238.5bTotal Revenue: ₩7.5tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Biotech Industry Price to Earnings3Y Average 66.4x202120222023
Current Industry PE
  • Investors are pessimistic on the South Korean Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 8.1x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does South Korean Biotech compare with similar industries?

KR Market0.36%
Healthcare-0.33%
Biotech-0.41%
Biotech-0.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A196170 ALTEOGEN₩78.60k6.9%
+₩263.9b
114.5%PE629.8x
A215600 SillaJen₩6.62k51.1%
+₩230.3b
-31.6%PS111.7x
A199800 ToolGen₩78.10k28.7%
+₩137.8b
49.3%PS951.7x
A310210 Voronoi₩41.80k9.7%
+₩61.7b
84.4%PS1183.9x
A086900 Medy-Tox₩223.50k4.0%
+₩57.2b
96.2%PE145.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A215600

₩6,620.00

SillaJen

7D

51.1%

1Y

-31.6%

A196170

₩78,600.00

ALTEOGEN

7D

6.9%

1Y

114.5%

A086900

₩223,500.00

Medy-Tox

7D

4.0%

1Y

96.2%

A310210

₩41,800.00

Voronoi

7D

9.7%

1Y

84.4%

A145020

₩151,600.00

Hugel

7D

-4.9%

1Y

32.6%

A191420

₩15,470.00

TegoScience

7D

37.8%

1Y

15.0%

A068270

₩161,700.00

Celltrion

7D

-6.2%

1Y

-4.5%

A358570

₩20,750.00

GI Innovation

7D

10.0%

1Y

n/a

A199800

₩78,100.00

ToolGen

7D

28.7%

1Y

49.3%

A217330

₩14,010.00

Cytogen

7D

-11.9%

1Y

-22.4%

A302440

₩67,800.00

SK bioscienceLtd

7D

-0.9%

1Y

-18.1%

A096530

₩22,050.00

Seegene

7D

4.3%

1Y

-27.5%

A182400

₩12,610.00

NKMAX

7D

-5.4%

1Y

-16.5%

A005690

₩6,110.00

Pharmicell

7D

-6.1%

1Y

-39.8%